Quarterly report pursuant to Section 13 or 15(d)

Share-Based Compensation - Summary of Number of Options Outstanding and Weighted-average Exercise Price (Details)

v3.23.1
Share-Based Compensation - Summary of Number of Options Outstanding and Weighted-average Exercise Price (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Compensation Related Costs [Abstract]    
Number of Shares, Options outstanding Beginning Balance 355,591  
Number of Shares, Granted 857,500  
Number of Shares, Options outstanding Ending Balance 1,213,091 355,591
Number of Shares, Exercisable at March 31, 2023 73,214  
Weighted Average Exercise Price, Options outstanding Beginning Balance $ 7.49  
Weighted Average Exercise Price, Granted 1.00  
Weighted Average Exercise Price, Options outstanding Ending Balance 2.90 $ 7.49
Weighted Average Exercise Price, Exercisable at March 31 2023 $ 19.42  
Weighted Average Remaining Contractual Life in Years, Options outstanding 9 years 8 months 1 day 9 years 1 month 13 days
Weighted Average Remaining Contractual Life in Years, Exercisable at March 31, 2023 (unaudited) 8 years 7 days  
Aggregate Intrinsic Value, Options outstanding $ 6